Skip to Content
Merck
CN

Caspase-1 recognizes extended cleavage sites in its natural substrates.

Atherosclerosis (2010-01-12)
Jerry Shen, Ying Yin, Jietang Mai, Xinyu Xiong, Meghana Pansuria, Jingshan Liu, Erin Maley, Najam Us Saqib, Hong Wang, Xiao-Feng Yang
ABSTRACT

The preferred amino acids in the proteolytic sites have been considered to be similar between caspase-1 and caspase-9, which do not support their differential functions in inflammatory pyroptosis and apoptosis. We attempted to solve this problem. We analyzed the flanking 20 amino acid residues in the cleavage sites in 34 caspase-1 and 11 capase-9 experimentally identified substrates. This study has made the following findings: first, we verified that caspase-1 and caspase-9 shared 100% aspartic acid in the P1 position. However, the structures in the cleavage sites of most caspase-1 substrates are different from that of caspase-9 substrates in the following three aspects, (a) the amino acid residues with the statistically high frequencies; (b) the hydrophobic amino acid occurrence frequencies; and (c) the charged amino acid occurrence frequencies; second, the amino acid pairs P1-P1' are different; third, our identified cleavage site patterns are useful in the prediction for the 91.4% cleavage sites of 35 new caspase-1 substrates. Since most caspase-1 substrates are involved in vascular function, inflammation and atherogenesis, our novel structural patterns for the caspases' substrates are significant in developing new diagnostics and therapeutics.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Caspase1 Substrate
Sigma-Aldrich
Caspase 1 Substrate
Sigma-Aldrich
Caspase 1 Substrate
Sigma-Aldrich
Caspase 1 Substrate
Sigma-Aldrich
Caspase 1 Substrate
Sigma-Aldrich
Caspase 1 Substrate
Sigma-Aldrich
Caspase 1 Substrate (ICE), fluorogenic
Sigma-Aldrich
Caspase 1 Substrate
Sigma-Aldrich
Caspase 1 Substrate, ≥92% (HPLC)